Diabetes drugs in short supply as they grow in popularity as weight-loss tool

A drug that helps lower blood sugar in adults with Type 2 diabetes is in short supply, as it has become increasingly popular among people using them to lose weight. There is limited availability in pharmacies of Novo Nordisk's diabetes drug Ozempic that is not expected to resolve until mid-March due to skyrocketing demand, prompting diabetes patients who depend on the drug to stretch out their supplies or switch to alternatives. Ozempic has only been approved by the Food and Drug Administration for treating diabetes, but its main ingredient, semaglutide, has been shown to help with weight loss. Read the full story here: https://www.washingtonexaminer.com/policy/healthcare/diabetes-drugs-short-supply-weight-loss-tool Check out our website: https://www.washingtonexaminer.com/